Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoprotein(a)”

338 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 338 results

Not applicableStudy completedNCT01690312
What this trial is testing

Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy

Who this might be right for
Cardiovascular Disease
Nutrasource Pharmaceutical and Nutraceutical Services, Inc. 36
Not applicableUnknownNCT05188430
What this trial is testing

Metabolic Effect of an Innovative Chitosan Formulation

Who this might be right for
HypercholesterolemiaOverweight and Obesity
University of Bologna 60
Post-approval studies (Phase 4)Study completedNCT00645151
What this trial is testing

The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512
Post-approval studies (Phase 4)Ended earlyNCT01025492
What this trial is testing

Study of Trilipix Effects on Lipids and Arteries

Who this might be right for
Dyslipidemia
University of Utah 24
Early research (Phase 1)Study completedNCT01959971
What this trial is testing

Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol

Who this might be right for
Hypercholesterolemia
Sanofi 20
Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Not applicableNot Yet RecruitingNCT07184034
What this trial is testing

Lipoprotein a Assessment and Relation to Ca Score in CAD Patients Using MSCT

Who this might be right for
Coronary Artery Disease (CAD)
Assiut University 150
Testing effectiveness (Phase 2)Study completedNCT02160899
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS-APO(a)Rx in Participants With High Lipoprotein(a)

Who this might be right for
Elevated Lipoprotein(a)
Ionis Pharmaceuticals, Inc. 64
Not applicableUnknownNCT01448577
What this trial is testing

Study to Re-assess and Re-confirm Data Previously Recorded About the Incidence and Severity of Acute Abdominal "Pancreatitis" Episodes in Lipoprotein Lipase Deficient (LPLD) Subjects Previously Enrolled on AMT Clinical Studies

Who this might be right for
Lipoprotein Lipase Deficiency
Amsterdam Molecular Therapeutics 22
Testing effectiveness (Phase 2)Study completedNCT00269048
What this trial is testing

SB-480848 In Subjects With Coronary Heart Disease

Who this might be right for
Atherosclerosis
GlaxoSmithKline 969
Not applicableStudy completedNCT00918918
What this trial is testing

Effect of Alcohol Consumption on Markers of Inflammation

Who this might be right for
Alcohol ConsumptionInflammation
TNO 24
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Very early researchStudy completedNCT02650726
What this trial is testing

Purified Anthocyanins Supplementation and High-Density Lipoprotein (HDL) Function

Who this might be right for
Diabetes Mellitus，Type 2
Sun Yat-sen University 80
Not applicableStudy completedNCT03918993
What this trial is testing

Effects of Tadalafil on LMR and MHR in Patients With ED

Who this might be right for
Erectile DysfunctionInflammation
Samsun Liv Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT05646381
What this trial is testing

Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Who this might be right for
Aortic Stenosis
Novartis Pharmaceuticals 502
Not applicableNot Yet RecruitingNCT07382414
What this trial is testing

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaLipoprotein(a)+1 more
Tor Biering-Sørensen 100,000
Not applicableStudy completedNCT07409636
What this trial is testing

Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 11,991
Not applicableStudy completedNCT06626659
What this trial is testing

Lipoprotein (a) and Vascular Regenerative Cell Content

Who this might be right for
Cardiovascular DiseasesAtherosclerosis Cardiovascular DiseaseIschemic Heart Disease+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 40
Not applicableStudy completedNCT02258932
What this trial is testing

CSII in Type 1 Diabetes: Diet, Quality of Life & Cardiometabolic Risks - A Longitudinal Study

Who this might be right for
Type 1 Diabetes
Liverpool John Moores University 5
Load More Results